Hence, here we conducted a systematic review and a meta-analysis to combine the findings from previous studies assessing Gal-1, -3, -8, and -9 as putative, non-invasive biomarkers of COVID-19 severity and COVID-19-related complications (e.g., cardiovascular). This evidence concerns the gene LGALS1 and COVID-19.